Preliminary inferences on the age-specific seriousness of human disease caused by avian influenza A(H7N9) infections in China, March to April 2013
Cowling BJ, et al. Preliminary inferences on the age-specific seriousness of human disease caused by avian influenza A(H7N9) infections in China, March to April 2013. Eurosurveillance 2013; 18: 20475.
Age-specific and sex-specific morbidity and mortality from avian influenza A (H7N9)
Dudley JP, Mackay IM. Age-specific and sex-specific morbidity and mortality from avian influenza A (H7N9). Journal of Clinical Virology 2013; 58: 568-570.
Epidemiological, clinical and viral characteristics of fatal cases of human avian influenza A (H7N9) virus in Zhejiang Province, China
Liu SL, et al. Epidemiological, clinical and viral characteristics of fatal cases of human avian influenza A (H7N9) virus in Zhejiang Province, China. Journal of Infection 2013; 67: 595-605.
Clinical features and factors associated with outcomes of patients infected with a novel influenza A (H7N9) virus: A preliminary study
Chen XR, et al. Clinical features and factors associated with outcomes of patients infected with a novel influenza A (H7N9) virus: a preliminary study. PLoS ONE 2013; 8: e73362.
Epidemiological and clinical characteristics and risk factors for death of patients with avian influenza A H7N9 virus infection from Jiangsu province, eastern China
Ji H, et al. Epidemiological and clinical characteristics and risk factors for death of patients with avian influenza A H7N9 virus infection from Jiangsu province, eastern China. PLoS ONE 2014; 9: e89581.
Kinetics of serological responses in influenza A(H7N9)-infected patients correlate with clinical outcome in China, 2013
Zhang A, et al. Kinetics of serological responses in influenza A(H7N9)-infected patients correlate with clinical outcome in China, 2013. Eurosurveillance 2013; 18: 20657.
Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance
Hu Y, et al. Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance. Lancet 2013; 381: 2273-2279.
Angiotensin II plasma levels are linked to disease severity and predict fatal outcomes in H7N9-infected patients
Huang F, et al. Angiotensin II plasma levels are linked to disease severity and predict fatal outcomes in H7N9-infected patients. Nature Communications 2014; 5: 3595.
National Health and Family Planning Commission. The guideline on diagnosis and treatment of human infection of H7N9 avian influenza (2014 edition) [in Chinese] (http://www.moh.gov.cn/yzygj/s3593g/201401/3f69fe196ecb4cfc8a2d6d96182f8b22.shtml). Accessed 23 May 2014.
National Health and Family Planning Commission. Outbreak prevention and control measurements of human infection of H7N9 avian influenza (third edition) [in Chinese] (http://www.moh.gov.cn/jkj/s3577/201401/8c1828375a7949cd85454a76bb84f23a.shtml). Accessed 23 May 2014.
High severity and fatality of human infections with avian influenza A(H7N9) infection in China
Ke Y, et al. High severity and fatality of human infections with avian influenza A(H7N9) infection in China. Clinical Infectious Diseases 2013; 57: 1506-1507.
Comparative epidemiology of human infections with avian influenza A H7N9 and H5N1 viruses in China: A population-based study of laboratory-confirmed cases
Cowling BJ, et al. Comparative epidemiology of human infections with avian influenza A H7N9 and H5N1 viruses in China: a population-based study of laboratory-confirmed cases. Lancet 2013; 382: 129-137.
Oseltamivir adherence and side effects among children in three London schools affected by influenza A(H1N1)V, May 2009 - An internet-based cross-sectional survey
Kitching A, et al. Oseltamivir adherence and side effects among children in three London schools affected by influenza A(H1N1)V, May 2009 - an internet-based cross-sectional survey. Eurosurveillance 2009; 14: 19287.